thimerosal has been researched along with Child Mental Disorders in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geier, DA; Geier, MR; Homme, KG; Kern, JK | 3 |
| Nanoff, C | 1 |
| Burbacher, TM; Curtis, B; Ferrier, C; Hewitson, L; Kenney, C; Liberato, N; Mandell, D; Marti, CN; Morrisroe, K; Rulien, M; Sackett, GP; Yutuc, V | 1 |
| Barrett, JR | 1 |
| Cerda, J | 1 |
| Dabanch, J; Potin, M | 1 |
| Lazarewicz, JW; Lenart, J; Zieminska, E | 1 |
9 other study(ies) available for thimerosal and Child Mental Disorders
| Article | Year |
|---|---|
A Cross-Sectional Study of the Association between Infant Hepatitis B Vaccine Exposure in Boys and the Risk of Adverse Effects as Measured by Receipt of Special Education Services.
Topics: Child; Cross-Sectional Studies; Education, Special; Hepatitis B Vaccines; Humans; Immunization; Logistic Models; Male; Mercury; Neurodevelopmental Disorders; Nutrition Surveys; Odds Ratio; Preservatives, Pharmaceutical; Thimerosal; United States | 2018 |
The risk of neurodevelopmental disorders following Thimerosal-containing Hib vaccine in comparison to Thimerosal-free Hib vaccine administered from 1995 to 1999 in the United States.
Topics: Adverse Drug Reaction Reporting Systems; Bacterial Capsules; Female; Haemophilus Vaccines; Humans; Infant; Male; Neurodevelopmental Disorders; Odds Ratio; Preservatives, Pharmaceutical; Risk; Thimerosal; United States | 2018 |
The fallacy of small sample size - Comment on: Geier D.A., Kern J.K., Homme K.G., Geier M.R., 2018. The risk of neurodevelopmental disorders following thimerosal-containing Hib vaccine in comparison to thimerosal-free Hib vaccine administered from 1995 to
Topics: Haemophilus influenzae type b; Humans; Neurodevelopmental Disorders; Sample Size; Thimerosal; United States | 2019 |
A critique that misses the mark.
Topics: Haemophilus influenzae type b; Humans; Neurodevelopmental Disorders; Thimerosal; United States | 2019 |
Examination of the safety of pediatric vaccine schedules in a non-human primate model: assessments of neurodevelopment, learning, and social behavior.
Topics: Animals; Case-Control Studies; Immunization Schedule; Learning; Macaca mulatta; Male; Models, Animal; Neurodevelopmental Disorders; Neurotoxins; Preservatives, Pharmaceutical; Social Behavior; Thimerosal; Vaccines | 2015 |
Pediatric vaccines and neurodevelopment: primate study finds no adverse behavioral effects.
Topics: Animals; Immunization Schedule; Learning; Male; Neurodevelopmental Disorders; Social Behavior; Thimerosal; Vaccines | 2015 |
[Controversy regarding the use of thimerosal in vaccines: evidence for decision making].
Topics: Decision Making; Evidence-Based Medicine; Humans; Neurodevelopmental Disorders; Patient Safety; Preservatives, Pharmaceutical; Thimerosal; Vaccines | 2015 |
[Thimerosal into vaccines: the law and the evidence].
Topics: Evidence-Based Medicine; Humans; Neurodevelopmental Disorders; Preservatives, Pharmaceutical; Thimerosal; Vaccines | 2015 |
Select putative neurodevelopmental toxins modify SNAP-25 expression in primary cultures of rat cerebellar granule cells.
Topics: Animals; Cells, Cultured; Cerebellum; Exocytosis; Gene Expression Regulation; Metal Nanoparticles; Neurodevelopmental Disorders; Neurons; Polybrominated Biphenyls; Rats; Rats, Wistar; RNA, Messenger; Silver; Synaptosomal-Associated Protein 25; Thalidomide; Thimerosal; Toxicity Tests; Valproic Acid | 2016 |